PlexusDx serves all 50 states with no insurance requirement and accepts HSA/FSA funds, making personalized dual therapy financially accessible
Among patients who were overweight or had obesity, 6.7% of those prescribed semaglutide developed NAION over 36 months, compared to 0.8% of those on other weight-loss medications
A review in the Journal of Clinical Endocrinology confirming that GHRH analog therapy produces significant improvements in body composition, sleep quality, and exercise capacity in aging adults supports its use in clinical anti-aging protocols
Progress can slow if habits remain unchanged, so ongoing adjustments in diet, activity, and routine are important to maintain results
Enclomiphene Citrate is a popular, attractive, sought-after PCT (Post-Cycle Therapy) or Test-Base product